Mainz Biomed (MYNZ) Shares Outstanding (Diluted Average) (2020 - 2024)
Historic Shares Outstanding (Diluted Average) for Mainz Biomed (MYNZ) over the last 3 years, with Q4 2022 value amounting to $14.2 million.
- Mainz Biomed's Shares Outstanding (Diluted Average) rose 9633.49% to $14.2 million in Q4 2022 from the same period last year, while for Dec 2022 it was $14.2 million, marking a year-over-year increase of 9633.49%. This contributed to the annual value of $14.2 million for FY2022, which is 9633.49% up from last year.
- Mainz Biomed's Shares Outstanding (Diluted Average) amounted to $14.2 million in Q4 2022, which was up 9633.49% from $7.2 million recorded in Q4 2021.
- Mainz Biomed's Shares Outstanding (Diluted Average)'s 5-year high stood at $14.2 million during Q4 2022, with a 5-year trough of $5.6 million in Q4 2020.
- For the 3-year period, Mainz Biomed's Shares Outstanding (Diluted Average) averaged around $9.0 million, with its median value being $7.2 million (2021).
- As far as peak fluctuations go, Mainz Biomed's Shares Outstanding (Diluted Average) soared by 2859.95% in 2021, and later surged by 9633.49% in 2022.
- Quarter analysis of 3 years shows Mainz Biomed's Shares Outstanding (Diluted Average) stood at $5.6 million in 2020, then grew by 28.6% to $7.2 million in 2021, then surged by 96.33% to $14.2 million in 2022.
- Its Shares Outstanding (Diluted Average) stands at $14.2 million for Q4 2022, versus $7.2 million for Q4 2021 and $5.6 million for Q4 2020.